The association of different auto-antibodies against ovarian tissues and gonadotropins and poor ovarian response in intracytoplasmic sperm injection cycles

References

• Calongos, G., Hasegawa, A., Komori, S., & Koyama, K. (2009). Harmful effects of anti-zona pellucida antibodies in folliculogenesis, oogenesis, and fertilization. Journal of Reproductive Immunology, 79, 148–155. doi: https://doi.org/10.1016/j.jri.2008.06.003.
   PubMed Web of Science ®Google Scholar
• Curtis, P., Burford, G., Amso, N., Keith, E., & Shaw, R.W. (1991). Assessment of the relevance of zona pellucida antibodies in serum and cervical mucus in patients who have fertilization failure during in vitro fertilization. Fertility and Sterility, 56, 1124–1127. doi: https://doi.org/10.1016/S0015-0282(16)54727-X.
   PubMed Web of Science ®Google Scholar
• Damewood, M.D., Zacur, H.A., Hoffman, G.J., & Rock, J.A. (1986). Circulating antiovarian antibodies in premature ovarian failure. Obstetrics and Gynecology, 68, 850–854. Retrieved from http://journals.lww.com/greenjournal/Abstract/1986/12000/Circulating_Antiovarian_Antibodies_in_Premature.23.aspx.
   PubMed Web of Science ®Google Scholar
• Ferraretti, A.P., La Marca, A., Fauser, B.C., Tarlatzis, B., Nargund, G., & Gianaroli, L. and on behalf of the ESHRE working group on Poor Ovarian Response Definition. (2011). ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: The Bologna criteria. Human Reproduction, 26, 1616–1624. doi: https://doi.org/10.1093/humrep/der092.
   PubMed Web of Science ®Google Scholar
• Forges, T., Monnier-Barbarino, P., Faure, G.C., & Bene, M.C. (2004). Autoimmunity and antigenic targets in ovarian pathology. Human Reproduction Update, 10, 163–175. doi: https://doi.org/10.1093/humupd/dmh014.
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco, J.A., & Somigliana, E. (2009). Management of endometriomas in women requiring IVF: To touch or not to touch. Human Reproduction, 24, 496–501. doi: https://doi.org/10.1093/humrep/den398.
   PubMed Web of Science ®Google Scholar
• Gobert, B., Barbarino-Monnier, P., Guillet-May, F., Bene, M.C., & Faure, G.C. (1992). Anti-ovary antibodies after attempts at human in vitro fertilization induced by follicular puncture rather than hormonal stimulation. Journal of Reproduction and Fertility, 96, 213–218. doi: https://doi.org/10.1530/jrf.0.0960213.
   PubMedGoogle Scholar
• Gupta, S.K. (2015). Role of zona pellucida glycoproteins during fertilization in humans. Journal of Reproductive Immunology, 108, 90–97. doi: https://doi.org/10.1016/j.jri.2014.08.006.
   PubMed Web of Science ®Google Scholar
• Haller, K., Salumets, A., & Uibo, R. (2008). Anti-FSH antibodies associate with poor outcome of ovarian stimulation in IVF. Reproductive Biomedicine Online, 16, 350–355. doi: https://doi.org/10.1016/S1472-6483(10)60595-0.
   PubMed Web of Science ®Google Scholar
• Hořejší, J., Martínek, J., Nováková, D., Madar, J., & Brandejska, M. (2000). Autoimmune antiovarian antibodies and their impact on the success of an IVF/ET program. Annals of the New York Academy of Sciences, 900, 351–356. doi: https://doi.org/10.1111/j.1749-6632.2000.tb06248.x.
   PubMed Web of Science ®Google Scholar
• Hovav, Y., Almagor, M., Benbenishti, D., Margalioth, E.J., Kafka, I., & Yaffe, H. (1994). Immunity to zona pellucida in women with low response to ovarian stimulation, in unexplained infertility and after multiple IVF attempts. Human Reproduction, 9, 643–645. Retrieved from http://humrep.oxfordjournals.org/content/9/4/643.
   PubMed Web of Science ®Google Scholar
• Howles, C.M. (2000). Role of LH and FSH in ovarian function. Molecular and Cellular Endocrinology, 161, 25–30. doi: https://doi.org/10.1016/S0303-7207(99)00219-1.
   PubMed Web of Science ®Google Scholar
• Jin, M., Larsson, A., & Nilsson, B.O. (1996). Monoclonal antibodies against unfertilized zona-free mouse oocytes: Characterization and effects on fertilization. Molecular Reproduction and Development, 43, 47–54. doi: https://doi.org/10.1002/(SICI)1098-2795(199601)43:1 < 47::AID-MRD6 > 3.0.CO;2-U.
   PubMed Web of Science ®Google Scholar
• Keay, S.D., Barlow, R., Eley, A., Masson, G.M., Anthony, F.W., & Jenkins, J.M. (1998). The relation between immunoglobulin G antibodies to Chlamydia trachomatis and poor ovarian response to gonadotropin stimulation before in vitro fertilization. Fertility and Sterility, 70, 214–218. doi: https://doi.org/10.1016/S0015-0282(98)00145-9.
   PubMed Web of Science ®Google Scholar
• Kelkar, R.L., Meherji, P.K., Kadam, S.S., Gupta, S.K., & Nandedkar, T.D. (2005). Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. Journal of Reproductive Immunology, 66, 53–67. doi: https://doi.org/10.1016/j.jri.2005.02.003.
   PubMed Web of Science ®Google Scholar
• Lamazou, F., Fuchs, F., Grynberg, M., Gallot, V., Herzog, E., Fanchin, R., … Frydman, R. (2012). Annulations en fécondation in vitro: mauvais pronostic, mauvaises répondeuses, ou variabilité de la réponse à la stimulation? Analyse de 142 annulations [Cancellation of IVF-ET cycles: Poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations]. Journal de Gyne´cologie, Obste´trique et Biologie de la Reproduction, 41, 41–47. doi: https://doi.org/10.1016/j.jgyn.2011.06.001.
   PubMed Web of Science ®Google Scholar
• Luborsky, J. (2002). Ovarian autoimmune disease and ovarian autoantibodies. Journal of Women’s Health & Gender-based Medicine, 11, 585–599. doi: https://doi.org/10.1089/152460902760360540
   PubMedGoogle Scholar
• Luborsky, J.L., Visintin, I., Boyers, S., Asari, T., Caldwell, B., & Decherney, A. (1990). Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. Journal of Clinical Endocrinology and Metabolism, 70, 69–75. doi: https://doi.org/10.1210/jcem-70-1-69.
   PubMed Web of Science ®Google Scholar
• Meyer, W.R., Lavy, G., Decherney, A.H., Visintin, I., Economy, K., & Luborsky, J.L. (1990). Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstetrics and Gynecology, 75, 795–799. Retrieved from http://journals.lww.com/greenjournal/Abstract/1990/05000/Evidence_of_Gonadal_and_Gonadotropin_Antibodies_in.14.aspx.
   PubMed Web of Science ®Google Scholar
• Narayanan, M., Murthy, P.S., Munaf, S.A., Shah, L.C., & Kini, M.D. (1995). Antiovarian antibodies and their effect on the outcome of assisted reproduction. Journal of Assisted Reproduction and Genetics, 12, 599–605. doi: https://doi.org/10.1007/BF02212582.
   PubMed Web of Science ®Google Scholar
• Pellicer, A., Lightman, A., Diamond, M.P., Russell, J.B., & Decherney, A.H. (1987). Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertility and Sterility, 47, 812–815. doi: https://doi.org/http://dx.doi.org/10.1016/S0015-0282(16)59170-5.
   PubMed Web of Science ®Google Scholar
• Pires, E.S., Parikh, F.R., Mande, P.V., Uttamchandani, S.A., Savkar, S., & Khole, V.V. (2011). Can anti-ovarian antibody testing be useful in an IVF-ET clinic? Journal of Assisted Reproduction and Genetics, 28, 55–64. doi: https://doi.org/10.1007/s10815-010-9488-2.
   PubMed Web of Science ®Google Scholar
• Reznik, Y., Benhaim, A., Morello, R., Herlicoviez, M., Ballet, J.J., & Mahoudeau, J. (1998). High frequency of IgG antagonizing follicle-stimulating hormone-stimulated steroidogenesis in infertile women with a good response to exogenous gonadotropins. Fertility and Sterility, 69, 46–52. doi: https://doi.org/10.1016/S0015-0282(97)00430-5.
   PubMed Web of Science ®Google Scholar
• Shatavi, S.V., Llanes, B., & Luborsky, J.L. (2006). Association of unexplained infertility with gonadotropin and ovarian antibodies. American Journal of Reproductive Immunology, 56, 286–291. doi: https://doi.org/10.1111/j.1600-0897.2006.00428.x.
   PubMed Web of Science ®Google Scholar
• Tong, Z.B., & Nelson, L.M. (1999). A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology, 140, 3720–3726. Retrieved from http://press.endocrine.org/doi/abs/10.1210/endo.140.8.6911https://doi.org/10.1210/endo.140.8.6911.
   PubMed Web of Science ®Google Scholar
• Vallotton, M.B., & Forbes, A.P. (1966). Antibodies to cytoplasm of ova. Lancet, 2, 264–265. doi: https://doi.org/10.1016/S0140-6736(66)92546-3.
   PubMed Web of Science ®Google Scholar
• Vollenhoven, B., Osianlis, T., & Catt, J. (2008). Is there an ideal stimulation regimen for IVF for poor responders and does it change with age? Journal of Assisted Reproduction and Genetics, 25, 523–529. doi: https://doi.org/10.1007/s10815-008-9274-6.
   PubMed Web of Science ®Google Scholar
• Zou, S.H., Zhang, P., Song, D.P., Li, B., & Wu, R.Y. (2008). Impact of antiovarian antibodies (AOA) on ovarian responsiveness in vitro fertilization and embryo transfer. Neuro Endocrinology Letters, 29, 949–952. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19112403.
   PubMed Web of Science ®Google Scholar